EJMA. 2022; 2(2): 88-89 | DOI: 10.14744/ejma.2022.03522
2Depertmant of Pediatric Radiology, University of Health Sciences, Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey
Infantile Hepatic Hemangioendothelioma with Complete Response to Propronalol Monotherapy
Özlem Terzi1, Hüseyin Avni Solğun1, Sümeyra Doğan2, Sibel Akpınar Tekgündüz1, Ali Ayçiçek11Depertmant of Pediatric Hematology and Oncology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey2Depertmant of Pediatric Radiology, University of Health Sciences, Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey
Infantile Hepatic Hemangioendothelioma (IHH) is an extremely rare and painless vascular tumor. IHH is usually in benign nature but it can also be life-threatening with a rapid growth tendency. There are approaches in the treatment of IHH, ranging from drug therapy to liver transplantation. Propranolol, which is used in first-line therapy for most patients, is effective alone in the treatment.
Keywords: Infantile hepatic hemangioendothelioma, propranolol, massive hepatomegaliÖzlem Terzi, Hüseyin Avni Solğun, Sümeyra Doğan, Sibel Akpınar Tekgündüz, Ali Ayçiçek. Infantile Hepatic Hemangioendothelioma with Complete Response to Propronalol Monotherapy. EJMA. 2022; 2(2): 88-89
Corresponding Author: Özlem Terzi, Türkiye
Manuscript Language: English
Corresponding Author: Özlem Terzi, Türkiye
Manuscript Language: English
Copyright © 2024 | Eurasian Journal of Medical Advances
